top of page
Gamma GT

Gamma GT

SKU: A-R0200000601

Product for use in the quantitative determination in vitro of the γ-GT concentration in human serum and plasma. The results of the test must always be interpreted in conjunction with the clinical context.

  • Tests per Kit

    938

  • Test Category

    Enzymes

  • Target Analytes

    γ-Glutamyltransferase (γ-GT)

  • Sample Type

    Serum or plasma

  • Kit Components

    R1: 4 x 42 mL;
    R2: 4 x 11 mL,
    Ready for use

  • Tech Docs

    Instructions for Use  |  Safety Data Sheet

  • Intended Use

    For professional use only.

  • Clinical Significance

    Although γ-GT IFCC is present in a large number of tissues, the enzyme which we wish to detect in the serum is principally part of the hepato-biliary system. Consequently, raised levels of γ-GT are seen in all forms of disease or damage to the hepatic system. From the clinical viewpoint, the enzyme is useful for the diagnosis of obstructive jaundice, cholangitis and cholecystitis. High γ-GT levels are also seen during the assumption of alcohol or pharmaceutical products (sedatives, anticonvulsants and tranquillisers).

  • Test Principle

    Gamma glutamyl transpeptidase (y-GT) catalyses the transfer of the g-glutamyl group from the substrate g-glutamyl-3-carboxy-4-nitroanilide to glycylglycine releasing Lglutamyl-glycylglycine and 5-amino-2-nitrobenzoato.
    L-γ-glutamyl-3-carboxi-4-nitroanilide + glycylglycine --(γ-GT)--> L-γ-glutamylglycylglycine + 5-amino-2-nitrobenzoate
    The rate of formation of 5-amino-2-nitrobenzoate, determined kinetically at 405 nm, is proportional to y-GT activity.

  • Stability & Storage

    Store at 2 - 8°C and protect from direct light. When correctly stored, the reagents are stable up the expiry date reported on the label. After opening, the vial R1 and R2 are stable 30 days if recapped immediately and protected from contamination, evaporation, direct light and stored at correct temperature

  • Required but Not Supplied

    Multicalibrator (R0300000006)
    Normal control serum (R0400000006)
    Pathological control serum (R0400000106)

Clinical Area
Method
Product Type
Packaging Unit
Compatible System
Regulatory Status

Related Products

bottom of page